Association Analyses Between the Genetic Polymorphisms of HNF4A and FOXO1 Genes and Chinese Han Patients with Type 2 Diabetes

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2011 Mar 29

PMID 21442235

Citations 5

Authors

Tianjie Li

XiaoPan Wu

XiLin Zhu

Jingyun Li

Liping Pan

Pengtao Li

ZhenHui Xin

Ying Liu

Affiliations

Soon will be listed here.

Abstract

The hepatocyte nuclear factor 4-alpha (HNF4A) and human forkhead box O1 (FOXO1) genes have been discovered to be associated with type 2 diabetes (T2D) in different populations. This study aimed to evaluate the association between HNF4A and FOXO1 genetic polymorphisms and type 2 diabetes in the Chinese Han population. Five hundred and seventy-seven patients with type 2 diabetes and 462 normal controls were enrolled in this study. Six single-nucleotide polymorphisms (SNPs) in HNF4A and seven in FOXO1 were selected and genotyped with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) or TaqMan(®) technology. Single-locus analyses indicated that the C allele of rs11574736 from HNF4A had a lower frequency in the case group compared with the control group (P = 0.005, OR = 0.74, 95% CI = 0.59-0.92). The genotype distributions of rs11574736 also differed between the two groups (P = 0.02). However, none of the FOXO1 SNPs showed any association with type 2 diabetes in the Chinese Han population. Further analysis suggested the two genes interact with each other (rs3908773/rs717247/rs6031587/rs11574736: P < 0.0001, testing accuracy = 0.55, CV consistency = 6/10). In conclusion, this study shows an association between the HNF4A gene and type 2 diabetes in the Chinese Han population. Moreover, the authors confirmed the results of previous studies for the interaction between HNF4A and FOXO1 in the pathogenesis of type 2 diabetes.

Citing Articles

Association study to evaluate Foxo1 and Foxo3 gene polymorphisms in polycystic ovary syndrome: a preliminary case-control study and in silico analysis.

Rakhshani Nejad A, Sargazi S, Ghasemi M, Samareh Moosavi S, Heidari Nia M, Saravani R Mol Biol Rep. 2023; 50(4):3569-3580.

PMID: 36790598 DOI: 10.1007/s11033-023-08292-w.

Association of FOXO1 Rs17592236 Polymorphism and Tumor Size in Papillary Thyroid Carcinoma.

Saljooghi S, Heidari Z, Saravani M, Rezaei M, Salimi S Rep Biochem Mol Biol. 2022; 11(2):216-223.

PMID: 36164628 PMC: 9455187. DOI: 10.52547/rbmb.11.2.216.

The FOXO1 Gene-Obesity Interaction Increases the Risk of Type 2 Diabetes Mellitus in a Chinese Han Population.

Gong L, Li R, Ren W, Wang Z, Wang Z, Yang M J Korean Med Sci. 2017; 32(2):264-271.

PMID: 28049237 PMC: 5219992. DOI: 10.3346/jkms.2017.32.2.264.

Predisposition to Behçet's disease and VKH syndrome by genetic variants of miR-182.

Yu H, Liu Y, Bai L, Kijlstra A, Yang P J Mol Med (Berl). 2014; 92(9):961-7.

PMID: 24801147 DOI: 10.1007/s00109-014-1159-9.

Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects.

Meshkani R, Saberi H, Mohammadtaghvaei N, Tabatabaiefar M Mol Cell Biochem. 2011; 359(1-2):225-33.

PMID: 21837403 DOI: 10.1007/s11010-011-1017-9.

References

Wang X, Tomso D, Chorley B, Cho H, Cheung V, Kleeberger S . Identification of polymorphic antioxidant response elements in the human genome. Hum Mol Genet. 2007; 16(10):1188-200. PMC: 2805149. DOI: 10.1093/hmg/ddm066. View

Ek J, Andersen G, Urhammer S, Gaede P, Drivsholm T, Borch-Johnsen K . Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia. 2002; 44(12):2220-6. DOI: 10.1007/s001250100032. View

Ido Kitamura Y, Kitamura T, Kruse J, Raum J, Stein R, Gu W . FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab. 2005; 2(3):153-63. DOI: 10.1016/j.cmet.2005.08.004. View

Buteau J, Shlien A, Foisy S, Accili D . Metabolic diapause in pancreatic beta-cells expressing a gain-of-function mutant of the forkhead protein Foxo1. J Biol Chem. 2006; 282(1):287-93. DOI: 10.1074/jbc.M606118200. View

Chen Z, Zhang D, Liu Y, Zhou D, Zhao T, Yang Y . Variants in hepatocyte nuclear factor 4alpha gene promoter region and type 2 diabetes risk in Chinese. Exp Biol Med (Maywood). 2010; 235(7):857-61. DOI: 10.1258/ebm.2010.010024. View

Wang F, Han X, Ren Q, Zhang X, Han L, Luo Y . Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population. Chin Med J (Engl). 2010; 122(20):2477-82. View

Hirota K, Sakamaki J, Ishida J, Shimamoto Y, Nishihara S, Kodama N . A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding. J Biol Chem. 2008; 283(47):32432-41. DOI: 10.1074/jbc.M806179200. View

Nakae J, Biggs 3rd W, Kitamura T, Cavenee W, Wright C, Arden K . Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet. 2002; 32(2):245-53. DOI: 10.1038/ng890. View

Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J . Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362(12):1090-101. DOI: 10.1056/NEJMoa0908292. View

10.

Boj S, Parrizas M, Maestro M, Ferrer J . A transcription factor regulatory circuit in differentiated pancreatic cells. Proc Natl Acad Sci U S A. 2001; 98(25):14481-6. PMC: 64707. DOI: 10.1073/pnas.241349398. View

11.

Eeckhoute J, Moerman E, Bouckenooghe T, Lukoviak B, Pattou F, Formstecher P . Hepatocyte nuclear factor 4 alpha isoforms originated from the P1 promoter are expressed in human pancreatic beta-cells and exhibit stronger transcriptional potentials than P2 promoter-driven isoforms. Endocrinology. 2003; 144(5):1686-94. DOI: 10.1210/en.2002-0024. View

12.

Karim M, Craig R, Wang X, Hale T, Elbein S . Analysis of FOXO1A as a candidate gene for type 2 diabetes. Mol Genet Metab. 2006; 88(2):171-7. DOI: 10.1016/j.ymgme.2006.01.003. View

13.

Okamoto H, Letizia Hribal M, Lin H, Bennett W, Ward A, Accili D . Role of the forkhead protein FoxO1 in beta cell compensation to insulin resistance. J Clin Invest. 2006; 116(3):775-82. PMC: 1370178. DOI: 10.1172/JCI24967. View

14.

Weedon M, Owen K, Shields B, Hitman G, Walker M, McCarthy M . Common variants of the hepatocyte nuclear factor-4alpha P2 promoter are associated with type 2 diabetes in the U.K. population. Diabetes. 2004; 53(11):3002-6. DOI: 10.2337/diabetes.53.11.3002. View

15.

Love-Gregory L, Wasson J, Ma J, Jin C, Glaser B, Suarez B . A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi jewish population. Diabetes. 2004; 53(4):1134-40. DOI: 10.2337/diabetes.53.4.1134. View

16.

Liu Y, Niu N, Zhu X, Du T, Wang X, Chen D . Genetic variation and association analyses of the nuclear respiratory factor 1 (nRF1) gene in Chinese patients with type 2 diabetes. Diabetes. 2007; 57(3):777-82. DOI: 10.2337/db07-0008. View

17.

Thomas H, Jaschkowitz K, Bulman M, Frayling T, Mitchell S, Roosen S . A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum Mol Genet. 2001; 10(19):2089-97. DOI: 10.1093/hmg/10.19.2089. View

18.

Silander K, Mohlke K, Scott L, Peck E, Hollstein P, Skol A . Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes. 2004; 53(4):1141-9. DOI: 10.2337/diabetes.53.4.1141. View

19.

DeFronzo R, Bonadonna R, Ferrannini E . Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992; 15(3):318-68. DOI: 10.2337/diacare.15.3.318. View

20.

Muller Y, Infante A, Hanson R, Love-Gregory L, Knowler W, Bogardus C . Variants in hepatocyte nuclear factor 4alpha are modestly associated with type 2 diabetes in Pima Indians. Diabetes. 2005; 54(10):3035-9. PMC: 1351112. DOI: 10.2337/diabetes.54.10.3035. View